[an error occurred while processing this directive]
Skip to Main Content

Latest News

Advertise Here
June 25, 2010

BASF Inks Bid For Cognis

Specialties: Latest acquisition will strengthen BASF’s position in home and personal care

Alexander H. Tullo

  • Print this article
  • Email the editor

Latest News

October 28, 2011

Speedy Homemade-Explosive Detector

Forensic Chemistry: A new method could increase the number of explosives detected by airport screeners.

Solar Panel Makers Cry Foul

Trade: U.S. companies complain of market dumping by China.

Novartis To Cut 2,000 Jobs

Layoffs follow similar moves by Amgen, AstraZeneca.

Nations Break Impasse On Waste

Environment: Ban to halt export of hazardous waste to developing world.

New Leader For Lawrence Livermore

Penrose (Parney) Albright will direct DOE national lab.

Hair Reveals Source Of People's Exposure To Mercury

Toxic Exposure: Mercury isotopes in human hair illuminate dietary and industrial sources.

Why The Long Fat?

Cancer Biochemistry: Mass spectrometry follows the metabolism of very long fatty acids in cancer cells.

Text Size A A

BASF will acquire Cognis and its facilities, including this one in Jacareí, Brazil, as part of a new deal. Cognis
BASF will acquire Cognis and its facilities, including this one in Jacareí, Brazil, as part of a new deal.

In a deal valued at $3.8 billion, BASF is buying personal care chemical maker Cognis from the private equity firms GS Capital Partners, Permira Funds, and SV Life Sciences.

The acquisition has been widely anticipated. Published reports have been circulating for months that BASF, the world’s largest chemical maker, was vying with the much smaller U.S. specialty chemical firm Lubrizol to purchase Cognis. In the end, BASF will pay $860 million in cash and assume about $2.9 billion of Cognis’ net debt and pension obligations.

Cognis, which has its headquarters in Monheim, Germany, had $3.2 billion in sales and $400 million in earnings before taxes in 2009. It was the chemical business of consumer products maker Henkel until the private equity firms purchased it in 2001.

With an emphasis on renewable raw materials, Cognis makes surfactants, emulsifiers, emollients, rheology modifiers, and active ingredients for the personal and home care sectors. It also produces nutritional ingredients such as sterols and vitamin E.

BASF says the acquisition will boost its position in the global personal care ingredients business from third to first, as well as solidify its leading position in home care.

“Our motto is to strengthen our strengths and eliminate our weaknesses,” BASF Chairman Jürgen Hambrecht told analysts. “We want to make our portfolio more competitive and cyclically resilient.”

The purchase extends a string of multi-billion-dollar mergers and acquisitions (M&A) for BASF. In 2006, it purchased Engelhard and acquired Degussa’s construction chemical business. Last year, it bought Ciba.

Analysts say Cognis is one of BASF’s better deals. “BASF’s acquisitions have yet to pay real dividends,” Morgan Stanley stock analyst Paul R. Walsh wrote in a note to clients, referring to the Degussa and Engelhard purchases. “As a result, there may be some skepticism surrounding yet more M&A for BASF.” But he argues that “Cognis represents a solid acquisition.”

Hambrecht told analysts that he now wants BASF to focus on improving cash flow, reducing debt, and maintaining a solid credit rating. “This means that there will be no further substantial acquisitions in the foreseeable future,” he said.

Chemical & Engineering News
ISSN 0009-2347
Copyright © 2011 American Chemical Society
  • Print this article
  • Email the editor

Services & Tools

ACS Resources

ACS is the leading employment source for recruiting scientific professionals. ACS Careers and C&EN Classifieds provide employers direct access to scientific talent both in print and online. Jobseekers | Employers

» Join ACS

Join more than 161,000 professionals in the chemical sciences world-wide, as a member of the American Chemical Society.
» Join Now!